995 related articles for article (PubMed ID: 14557656)
1. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
[TBL] [Abstract][Full Text] [Related]
2. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
[TBL] [Abstract][Full Text] [Related]
3. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.
Shacklett BL; Cox CA; Sandberg JK; Stollman NH; Jacobson MA; Nixon DF
J Virol; 2003 May; 77(10):5621-31. PubMed ID: 12719554
[TBL] [Abstract][Full Text] [Related]
4. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
5. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration.
George MD; Reay E; Sankaran S; Dandekar S
J Virol; 2005 Mar; 79(5):2709-19. PubMed ID: 15708990
[TBL] [Abstract][Full Text] [Related]
6. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
7. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses.
Macal M; Sankaran S; Chun TW; Reay E; Flamm J; Prindiville TJ; Dandekar S
Mucosal Immunol; 2008 Nov; 1(6):475-88. PubMed ID: 19079215
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of HIV in the gastrointestinal tract.
Dandekar S
Curr HIV/AIDS Rep; 2007 Feb; 4(1):10-5. PubMed ID: 17338855
[TBL] [Abstract][Full Text] [Related]
11. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
[TBL] [Abstract][Full Text] [Related]
12. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.
Blankson JN; Gallant JE; Siliciano RF
J Infect Dis; 2001 Feb; 183(4):657-61. PubMed ID: 11170994
[TBL] [Abstract][Full Text] [Related]
13. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
[TBL] [Abstract][Full Text] [Related]
14. The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection.
Ribeiro SP; Milush JM; Cunha-Neto E; Kallas EG; Kalil J; Somsouk M; Hunt PW; Deeks SG; Nixon DF; SenGupta D
J Virol; 2014 Dec; 88(23):13836-44. PubMed ID: 25253339
[TBL] [Abstract][Full Text] [Related]
15. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.
Mehandru S; Poles MA; Tenner-Racz K; Jean-Pierre P; Manuelli V; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
PLoS Med; 2006 Dec; 3(12):e484. PubMed ID: 17147468
[TBL] [Abstract][Full Text] [Related]
16. HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment.
Rueda CM; Velilla PA; Chougnet CA; Montoya CJ; Rugeles MT
PLoS One; 2012; 7(1):e30307. PubMed ID: 22276176
[TBL] [Abstract][Full Text] [Related]
17. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
[TBL] [Abstract][Full Text] [Related]
18. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
[TBL] [Abstract][Full Text] [Related]
19. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
20. Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
Evering TH; Mehandru S; Racz P; Tenner-Racz K; Poles MA; Figueroa A; Mohri H; Markowitz M
PLoS Pathog; 2012 Feb; 8(2):e1002506. PubMed ID: 22319447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
